dc.contributor.author | Thiele, Stefanie | |
dc.contributor.author | Mungalpara, Jignesh | |
dc.contributor.author | Steen, A. | |
dc.contributor.author | Rosenkilde, Mette M. | |
dc.contributor.author | Våbenø, Jon | |
dc.date.accessioned | 2015-03-05T11:04:54Z | |
dc.date.available | 2015-03-05T11:04:54Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | British Journal of Pharmacology 171(2014) nr. 23 s. 5313-5329 | en_US |
dc.identifier.cristinID | FRIDAID 1187718 | |
dc.identifier.doi | 10.1111/bph.12842 | |
dc.identifier.issn | 0007-1188 | |
dc.identifier.uri | https://hdl.handle.net/10037/7344 | |
dc.identifier.urn | URN:NBN:no-uit_munin_6915 | |
dc.language.iso | eng | en_US |
dc.publisher | Macmillan Press Ltd. | en_US |
dc.rights.accessRights | openAccess | |
dc.subject | VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Farmakologi: 728 | en_US |
dc.subject | VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Pharmacology: 728 | en_US |
dc.title | Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |